Biological Sealants Market by Indication, Application, Product, Region – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2029
9.1%
CAGR (2023-2029)
2 USD Bn.
Market Size
317
Report Pages
148
Market Tables
Overview
Biological Sealants Market is expected to reach US$ 3.69 Bn. by 2029, at a CAGR of 9.1% during the forecast period.
The report covers an in-depth analysis of COVID 19 pandemic impact on Global Biological Sealants Market by region and on the key players’ revenue affected till July 2020 and expected short term and long-term impact on the market.
Biological Sealants Market Overview
The global biological sealant market is expected to show a robust growth over the forecast period owing to the rising adoption of new innovative surgeries that are simpler, quicker, and safer. The biological sealants are one of the most versatile advanced technologies as it is most adopted by various neurosurgeons and tissue engineering segments. It also provides adequate support for wound care and helps to heal tissues. Besides, it is among the most favored accompaniments by surgeons; current surgical techniques use biological sealants in various applications. It is expected that the rising need to minimize surgical issues and the rising demand for surgical services is expected to grow with robust development in the technology over the forecast period.
To know about the Research Methodology :- Request Free Sample Report
Biological Sealants Market Dynamics
The biological sealant has various advantages such as efficiency, safety, and ease in usability and these advantages have made biological sealants a widespread prominence. Also, conventional surgical has more advantages over traditional methods which include sutures and staples. Besides, it is used in a combination of staples and sutures for emergency care in the case of gas or fluid sealing and haemostasis. The biological sealants help reduce the use of the sutures by forming or bounding a chemical barrier to control the ooziness, blood, or body fluids after surgery or injury. In addition, they help substantially reduce the risk of transmission of blood-borne illness, tissue reactivity, and infection.
However, government stringent regulations associated with extensive handling, high infection rate, length of the surgery, and consumer awareness may hamper the growth of the market. Expensive cost for R & D in biological sealants may slow down the biological sealants market.
Over the coming years, the increased use of biological sealants for integrated soft tissue and the restoration of tissue functionality has gained a lot of significance. This consideration also has a positive effect on the demand for biological sealants as less suture fewer practices could be augmented. The engineering tissue segment based on indication is expected a robust growth over the forecast period owing to growing needs of the conventional advanced method of surgeries which is efficient, safety. Besides, increases the demand in cosmetic surgeries is one of the key factors that has boosted the demand for the biological sealants market. In case of a burn or skin injuries, this has impacted a growing need for tissue generation and is expected a robust growth over the forecast period.
Biological Sealants Market Segmentation
Global Biological Sealants Market is segmented by Indication (Tissue Sealing, Surgical Hemostasis, Tissue Engineering, Polymeric Hydrogels), by Application (Central Nervous System (CNS) Surgeries, General Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Cosmetic Surgeries, Ophthalmic Surgeries, Urological Surgeries, Pulmonary Surgeries), by Product (Natural or Biological, Fibrin, Collagen Based, Synthetic and Semi Synthetic, Cyanoacrylates, Polymeric Hydrogels) by Region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
Biological Sealants Market Regional Analysis
The regional analysis of the worldwide Biological Sealants market is segregated across North America, Europe, Asia Pacific, the Middle East and Africa, and South America.
By region, North America is dominating the biological sealant market and is expected to be in the leading position over the years. The rising favorable healthcare policies, high-quality healthcare, surgical care, and modern healthcare technology are driving the growth of the biological sealants market in this region. Manufacturing, together with expansion and acquisition with global players, is taking a keen interest in building a strong business footprint that has had a positive impact in this region. The Asia Pacific is expected to show a robust growth as the increase in healthcare practices are increasing the demand for biological sealants. The increasing applications along with increases in healthcare practices at an affordable cost and implementation of new techniques is driving the biological sealants market over the forecast period.
Report covers in-depth analysis of key development, marketing strategies, supply-side and demand side indicators and company profiles of market leaders, potential players, and new entrants. Key players operating in this market are adopting various organic and inorganic growth strategies such as merger& acquisitions, joint ventures, collaborations, expansion, new product launches and patents to increase their regional presence and business operations.
The objective of the report is to present a comprehensive analysis of the Global Biological Sealants Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Biological Sealants Market dynamics, structure by analyzing the market segments and project Global Biological Sealants Market Clear representation of competitive analysis of key players by price, financial position, Product portfolio, growth strategies, and regional presence in the Global Biological Sealants Market make the report investor’s guide.
Biological Sealants Market Scope: Inquire before buying
| Biological Sealants Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2017 to 2022 | Market Size in 2022: | US $ 2.00 Bn. |
| Forecast Period 2023 to 2029 CAGR: | 9.1% | Market Size in 2029: | US $ 3.69 Bn. |
| Segments Covered: | by Indication | • Tissue Sealing • Surgical Hemostasis • Tissue Engineering • Polymeric Hydrogels |
|
| by Application | • Central Nervous System (CNS) Surgeries • General Surgeries • Cardiovascular Surgeries • Orthopedic Surgeries • Cosmetic Surgeries • Ophthalmic Surgeries • Urological Surgeries • Pulmonary Surgeries |
||
| by Product | • Natural or Biological • Fibrin • Collagen Based • Synthetic and Semi Synthetic • Cyanoacrylates • Polymeric Hydrogels |
||
| by Region | • North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America) |
||
Biological Sealants Market Key Players
• Baxter International, Inc.
• CryoLife, Inc.
• C.R. Bard, Inc.
• Medtronic PLC
• B. Braun Melsungen AG
• Cohera Medical, Inc.
• Ethicon, Inc. [J&J]
• Mallinckrodt plc
• Cardinal Health
• B. Braun Melsungen AG
• Medtronic Plc.
• CryoLife, Inc.
• Ocular Therapeutix
• Sealantis Ltd
• Johnson & Johnson (Ethicon, Inc.)
• Becton
• Dickinson and Company
• CryoLife, Inc.
• Cardinal Health, Inc.
• B. Braun Melsungen AG
• Integra Lifesciences Holdings Corporation
• Medline Industries, Inc.
• Adhezion Biomedical, LLC
• Tricol Biomedical, Inc.
Frequently Asked Questions:
1. Which region has the largest share in Global Biological Sealants Market?
Ans: North America region held the highest share in 2022.
2. What is the growth rate of Global Biological Sealants Market?
Ans: The Global Biological Sealants Market is growing at a CAGR of 9.1% during forecasting period 2023-2029.
3. What is scope of the Global Biological Sealants Market report?
Ans: Global Biological Sealants Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Biological Sealants Market?
Ans: The important key players in the Global Biological Sealants Market are – Baxter International, Inc., CryoLife, Inc., C.R. Bard, Inc., Medtronic PLC, B. Braun Melsungen AG, Cohera Medical, Inc., Ethicon, Inc. [J&J], Mallinckrodt plc, Cardinal Health, B. Braun Melsungen AG, Medtronic Plc., CryoLife, Inc., Ocular Therapeutix, Sealantis Ltd, Johnson & Johnson (Ethicon, Inc.), Becton, Dickinson and Company, CryoLife, Inc., Cardinal Health, Inc., B. Braun Melsungen AG, Integra Lifesciences Holdings Corporation, Medline Industries, Inc., Adhezion Biomedical, LLC, Tricol Biomedical, Inc.
5. What is the study period of this Market?
Ans: The Global Biological Sealants Market is studied from 2022 to 2029.
Table of Contents
Global Biological Sealants Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Biological Sealants Market, by Market Value (US$ Bn) and Volume (Ton)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Biological Sealants Market Analysis and Forecas
6.1. Global Biological Sealants Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Biological Sealants Market Analysis and Forecast, by Indication
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Biological Sealants Market Value Share Analysis, by Indication
7.4. Global Biological Sealants Market Size (US$ Bn) Forecast, by Indication
7.5. Global Biological Sealants Market Analysis, by Indication
7.6. Global Biological Sealants Market Attractiveness Analysis, by Indication
8. Global Biological Sealants Market Analysis and Forecast, by Application
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Biological Sealants Market Value Share Analysis, by Application
8.4. Global Biological Sealants Market Size (US$ Bn) Forecast, by Application
8.5. Global Biological Sealants Market Analysis, by Application
8.6. Global Biological Sealants Market Attractiveness Analysis, by Application
9. Global Biological Sealants Market Analysis and Forecast, by Product
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Biological Sealants Market Value Share Analysis, by Product
9.4. Global Biological Sealants Market Size (US$ Bn) Forecast, by Product
9.5. Global Biological Sealants Market Analysis, by Product
9.6. Global Biological Sealants Market Attractiveness Analysis, by Product
10. Global Biological Sealants Market Analysis, by Region
10.1. Global Biological Sealants Market Value Share Analysis, by Region
10.2. Global Biological Sealants Market Size (US$ Bn) Forecast, by Region
10.3. Global Biological Sealants Market Attractiveness Analysis, by Region
11. North America Biological Sealants Market Analysis
11.1. Key Findings
11.2. North America Biological Sealants Market Overview
11.3. North America Biological Sealants Market Value Share Analysis, by Indication
11.4. North America Biological Sealants Market Forecast, by Indication
11.4.1. Tissue Sealing
11.4.2. Surgical Hemostasis
11.4.3. Polymeric Hydrogels
11.4.4. Tissue Engineering
11.5. North America Biological Sealants Market Value Share Analysis, by Application
11.6. North America Biological Sealants Market Forecast, by Application
11.6.1. Central Nervous System (CNS) Surgeries
11.6.2. General Surgeries
11.6.3. Cardiovascular surgeries
11.6.4. Orthopedic Surgeries
11.6.5. Cosmetic Surgeries
11.6.6. Ophthalmic Surgeries
11.6.7. Urological Surgeries
11.6.8. Pulmonary Surgeries
11.7. North America Biological Sealants Market Value Share Analysis, by Product
11.8. North America Biological Sealants Market Forecast, by Product
11.8.1. Natural or Biological
11.8.2. Fibrin
11.8.3. Collagen Based
11.8.4. Synthetic and Semi Synthetic
11.8.5. Cyanoacrylates
11.8.6. Polymeric Hydrogels
11.9. North America Biological Sealants Market Value Share Analysis, by Country
11.10. North America Biological Sealants Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Biological Sealants Market Analysis, by Country
11.12. U.S. Biological Sealants Market Forecast, by Indication
11.12.1. Tissue Sealing
11.12.2. Surgical Hemostasis
11.12.3. Tissue Engineering
11.12.4. Polymeric Hydrogels
11.13. U.S. Biological Sealants Market Forecast, by Application
11.13.1. Central Nervous System (CNS) Surgeries
11.13.2. General Surgeries
11.13.3. Cardiovascular surgeries
11.13.4. Orthopedic Surgeries
11.13.5. Cosmetic Surgeries
11.13.6. Ophthalmic Surgeries
11.13.7. Urological Surgeries
11.13.8. Pulmonary Surgeries
11.14. U.S. Biological Sealants Market Forecast, by Product
11.14.1. Natural or Biological
11.14.2. Fibrin
11.14.3. Collagen Based
11.14.4. Synthetic and Semi Synthetic
11.14.5. Cyanoacrylates
11.14.6. Polymeric Hydrogels
11.15. Canada Biological Sealants Market Forecast, by Indication
11.15.1. Tissue Sealing
11.15.2. Surgical Hemostasis
11.15.3. Tissue Engineering
11.15.4. Polymeric Hydrogels
11.16. Canada Biological Sealants Market Forecast, by Application
11.16.1. Central Nervous System (CNS) Surgeries
11.16.2. General Surgeries
11.16.3. Cardiovascular surgeries
11.16.4. Orthopedic Surgeries
11.16.5. Cosmetic Surgeries
11.16.6. Ophthalmic Surgeries
11.16.7. Urological Surgeries
11.16.8. Pulmonary Surgeries
11.17. Canada Biological Sealants Market Forecast, by Product
11.17.1. Natural or Biological
11.17.2. Fibrin
11.17.3. Collagen Based
11.17.4. Synthetic and Semi Synthetic
11.17.5. Cyanoacrylates
11.17.6. Polymeric Hydrogels
11.18. North America Biological Sealants Market Attractiveness Analysis
11.18.1. By Indication
11.18.2. By Application
11.18.3. By Product
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Development
12. Europe Biological Sealants Market Analysis
12.1. Key Findings
12.2. Europe Biological Sealants Market Overview
12.3. Europe Biological Sealants Market Value Share Analysis, by Indication
12.4. Europe Biological Sealants Market Forecast, by Indication
12.4.1. Tissue Sealing
12.4.2. Surgical Hemostasis
12.4.3. Tissue Engineering
12.4.4. Polymeric Hydrogels
12.5. Europe Biological Sealants Market Value Share Analysis, by Application
12.6. Europe Biological Sealants Market Forecast, by Application
12.6.1. Central Nervous System (CNS) Surgeries
12.6.2. General Surgeries
12.6.3. Cardiovascular surgeries
12.6.4. Orthopedic Surgeries
12.6.5. Cosmetic Surgeries
12.6.6. Ophthalmic Surgeries
12.6.7. Urological Surgeries
12.6.8. Pulmonary Surgeries
12.7. Europe Biological Sealants Market Value Share Analysis, by Product
12.8. Europe Biological Sealants Market Forecast, by Product
12.8.1. Natural or Biological
12.8.2. Fibrin
12.8.3. Collagen Based
12.8.4. Synthetic and Semi Synthetic
12.8.5. Cyanoacrylates
12.8.6. Polymeric Hydrogels
12.9. Europe Biological Sealants Market Value Share Analysis, by Country
12.10. Europe Biological Sealants Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Norway
12.10.7. Rest of Europe
12.11. Europe Biological Sealants Market Analysis, by Country
12.12. Germany Biological Sealants Market Forecast, by Indication
12.12.1. Tissue Sealing
12.12.2. Surgical Hemostasis
12.12.3. Tissue Engineering
12.12.4. Polymeric Hydrogels
12.13. Germany Biological Sealants Market Forecast, by Application
12.13.1. Central Nervous System (CNS) Surgeries
12.13.2. General Surgeries
12.13.3. Cardiovascular surgeries
12.13.4. Orthopedic Surgeries
12.13.5. Cosmetic Surgeries
12.13.6. Ophthalmic Surgeries
12.13.7. Urological Surgeries
12.13.8. Pulmonary Surgeries
12.14. Germany Biological Sealants Market Forecast, by Product
12.14.1. Natural or Biological
12.14.2. Fibrin
12.14.3. Collagen Based
12.14.4. Synthetic and Semi Synthetic
12.14.5. Cyanoacrylates
12.14.6. Polymeric Hydrogels
12.15. U.K. Biological Sealants Market Forecast, by Indication
12.15.1. Tissue Sealing
12.15.2. Surgical Hemostasis
12.15.3. Tissue Engineering
12.15.4. Polymeric Hydrogels
12.16. U.K. Biological Sealants Market Forecast, by Application
12.16.1. Central Nervous System (CNS) Surgeries
12.16.2. General Surgeries
12.16.3. Cardiovascular surgeries
12.16.4. Orthopedic Surgeries
12.16.5. Cosmetic Surgeries
12.16.6. Ophthalmic Surgeries
12.16.7. Urological Surgeries
12.16.8. Pulmonary Surgeries
12.17. U.K. Biological Sealants Market Forecast, by Product
12.17.1. Natural or Biological
12.17.2. Fibrin
12.17.3. Collagen Based
12.17.4. Synthetic and Semi Synthetic
12.17.5. Cyanoacrylates
12.17.6. Polymeric Hydrogels
12.18. France Biological Sealants Market Forecast, by Indication
12.18.1. Tissue Sealing
12.18.2. Surgical Hemostasis
12.18.3. Tissue Engineering
12.18.4. Polymeric Hydrogels
12.19. France Biological Sealants Market Forecast, by Application
12.19.1. Central Nervous System (CNS) Surgeries
12.19.2. General Surgeries
12.19.3. Cardiovascular surgeries
12.19.4. Orthopedic Surgeries
12.19.5. Cosmetic Surgeries
12.19.6. Ophthalmic Surgeries
12.19.7. Urological Surgeries
12.19.8. Pulmonary Surgeries
12.20. France Biological Sealants Market Forecast, by Product
12.20.1. Natural or Biological
12.20.2. Fibrin
12.20.3. Collagen Based
12.20.4. Synthetic and Semi Synthetic
12.20.5. Cyanoacrylates
12.20.6. Polymeric Hydrogels
12.21. Italy Biological Sealants Market Forecast, by Indication
12.21.1. Tissue Sealing
12.21.2. Surgical Hemostasis
12.21.3. Tissue Engineering
12.21.4. Polymeric Hydrogels
12.22. Italy Biological Sealants Market Forecast, by Application
12.22.1. Central Nervous System (CNS) Surgeries
12.22.2. General Surgeries
12.22.3. Cardiovascular surgeries
12.22.4. Orthopedic Surgeries
12.22.5. Cosmetic Surgeries
12.22.6. Ophthalmic Surgeries
12.22.7. Urological Surgeries
12.22.8. Pulmonary Surgeries
12.23. Italy Biological Sealants Market Forecast, by Product
12.23.1. Natural or Biological
12.23.2. Fibrin
12.23.3. Collagen Based
12.23.4. Synthetic and Semi Synthetic
12.23.5. Cyanoacrylates
12.23.6. Polymeric Hydrogels
12.24. Spain Biological Sealants Market Forecast, by Indication
12.24.1. Tissue Sealing
12.24.2. Surgical Hemostasis
12.24.3. Tissue Engineering
12.24.4. Polymeric Hydrogels
12.25. Spain Biological Sealants Market Forecast, by Application
12.25.1. Central Nervous System (CNS) Surgeries
12.25.2. General Surgeries
12.25.3. Cardiovascular surgeries
12.25.4. Orthopedic Surgeries
12.25.5. Cosmetic Surgeries
12.25.6. Ophthalmic Surgeries
12.25.7. Urological Surgeries
12.25.8. Pulmonary Surgeries
12.26. Spain Biological Sealants Market Forecast, by Product
12.26.1. Natural or Biological
12.26.2. Fibrin
12.26.3. Collagen Based
12.26.4. Synthetic and Semi Synthetic
12.26.5. Cyanoacrylates
12.26.6. Polymeric Hydrogels
12.27. Norway Biological Sealants Market Forecast, by Indication
12.27.1. Tissue Sealing
12.27.2. Surgical Hemostasis
12.27.3. Tissue Engineering
12.27.4. Polymeric Hydrogels
12.28. Norway Biological Sealants Market Forecast, by Application
12.28.1. Central Nervous System (CNS) Surgeries
12.28.2. General Surgeries
12.28.3. Cardiovascular surgeries
12.28.4. Orthopedic Surgeries
12.28.5. Cosmetic Surgeries
12.28.6. Ophthalmic Surgeries
12.28.7. Urological Surgeries
12.28.8. Pulmonary Surgeries
12.29. Norway Biological Sealants Market Forecast, by Product
12.29.1. Natural or Biological
12.29.2. Fibrin
12.29.3. Collagen Based
12.29.4. Synthetic and Semi Synthetic
12.29.5. Cyanoacrylates
12.29.6. Polymeric Hydrogels
12.30. Rest of Europe Biological Sealants Market Forecast, by Indication
12.30.1. Tissue Sealing
12.30.2. Surgical Hemostasis
12.30.3. Tissue Engineering
12.30.4. Polymeric Hydrogels
12.31. Rest of Europe Biological Sealants Market Forecast, by Application
12.31.1. Central Nervous System (CNS) Surgeries
12.31.2. General Surgeries
12.31.3. Cardiovascular surgeries
12.31.4. Orthopedic Surgeries
12.31.5. Cosmetic Surgeries
12.31.6. Ophthalmic Surgeries
12.31.7. Urological Surgeries
12.31.8. Pulmonary Surgeries
12.32. Rest of Europe Biological Sealants Market Forecast, by Product
12.32.1. Natural or Biological
12.32.2. Fibrin
12.32.3. Collagen Based
12.32.4. Synthetic and Semi Synthetic
12.32.5. Cyanoacrylates
12.32.6. Polymeric Hydrogels
12.33. Europe Biological Sealants Market Attractiveness Analysis
12.33.1. By Indication
12.33.2. By Application
12.33.3. By Product
12.34. PEST Analysis
12.35. Key Trends
12.36. Key Development
13. Asia Pacific Biological Sealants Market Analysis
13.1. Key Findings
13.2. Asia Pacific Biological Sealants Market Overview
13.3. Asia Pacific Biological Sealants Market Value Share Analysis, by Indication
13.4. Asia Pacific Biological Sealants Market Forecast, by Indication
13.4.1. Tissue Sealing
13.4.2. Surgical Hemostasis
13.4.3. Tissue Engineering
13.4.4. Polymeric Hydrogels
13.5. Asia Pacific Biological Sealants Market Value Share Analysis, by Application
13.6. Asia Pacific Biological Sealants Market Forecast, by Application
13.6.1. Central Nervous System (CNS) Surgeries
13.6.2. General Surgeries
13.6.3. Cardiovascular surgeries
13.6.4. Orthopedic Surgeries
13.6.5. Cosmetic Surgeries
13.6.6. Ophthalmic Surgeries
13.6.7. Urological Surgeries
13.6.8. Pulmonary Surgeries
13.7. Asia Pacific Biological Sealants Market Value Share Analysis, by Product
13.8. Asia Pacific Biological Sealants Market Forecast, by Product
13.8.1. Natural or Biological
13.8.2. Fibrin
13.8.3. Collagen Based
13.8.4. Synthetic and Semi Synthetic
13.8.5. Cyanoacrylates
13.8.6. Polymeric Hydrogels
13.9. Asia Pacific Biological Sealants Market Value Share Analysis, by Country
13.10. Asia Pacific Biological Sealants Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. South Korea
13.10.5. Australia
13.10.6. Malaysia
13.10.7. Indonesia
13.10.8. Vietnam
13.10.9. Rest of Asia Pacific
13.11. Asia Pacific Biological Sealants Market Analysis, by Country
13.12. China Biological Sealants Market Forecast, by Indication
13.12.1. Tissue Sealing
13.12.2. Surgical Hemostasis
13.12.3. Tissue Engineering
13.12.4. Polymeric Hydrogels
13.13. China Biological Sealants Market Forecast, by Application
13.13.1. Central Nervous System (CNS) Surgeries
13.13.2. General Surgeries
13.13.3. Cardiovascular surgeries
13.13.4. Orthopedic Surgeries
13.13.5. Cosmetic Surgeries
13.13.6. Ophthalmic Surgeries
13.13.7. Urological Surgeries
13.13.8. Pulmonary Surgeries
13.14. China Biological Sealants Market Forecast, by Product
13.14.1. Natural or Biological
13.14.2. Fibrin
13.14.3. Collagen Based
13.14.4. Synthetic and Semi Synthetic
13.14.5. Cyanoacrylates
13.14.6. Polymeric Hydrogels
13.15. India Biological Sealants Market Forecast, by Indication
13.15.1. Tissue Sealing
13.15.2. Surgical Hemostasis
13.15.3. Tissue Engineering
13.15.4. Polymeric Hydrogels
13.16. India Biological Sealants Market Forecast, by Application
13.16.1. Central Nervous System (CNS) Surgeries
13.16.2. General Surgeries
13.16.3. Cardiovascular surgeries
13.16.4. Orthopedic Surgeries
13.16.5. Cosmetic Surgeries
13.16.6. Ophthalmic Surgeries
13.16.7. Urological Surgeries
13.16.8. Pulmonary Surgeries
13.17. India Biological Sealants Market Forecast, by Product
13.17.1. Natural or Biological
13.17.2. Fibrin
13.17.3. Collagen Based
13.17.4. Synthetic and Semi Synthetic
13.17.5. Cyanoacrylates
13.17.6. Polymeric Hydrogels
13.18. Japan Biological Sealants Market Forecast, by Indication
13.18.1. Tissue Sealing
13.18.2. Surgical Hemostasis
13.18.3. Tissue Engineering
13.18.4. Polymeric Hydrogels
13.19. Japan Biological Sealants Market Forecast, by Application
13.19.1. Central Nervous System (CNS) Surgeries
13.19.2. General Surgeries
13.19.3. Cardiovascular surgeries
13.19.4. Orthopedic Surgeries
13.19.5. Cosmetic Surgeries
13.19.6. Ophthalmic Surgeries
13.19.7. Urological Surgeries
13.19.8. Pulmonary Surgeries
13.20. Japan Biological Sealants Market Forecast, by Product
13.20.1. Natural or Biological
13.20.2. Fibrin
13.20.3. Collagen Based
13.20.4. Synthetic and Semi Synthetic
13.20.5. Cyanoacrylates
13.20.6. Polymeric Hydrogels
13.21. Australia Biological Sealants Market Forecast, by Indication
13.21.1. Tissue Sealing
13.21.2. Surgical Hemostasis
13.21.3. Tissue Engineering
13.21.4. Polymeric Hydrogels
13.22. Australia Biological Sealants Market Forecast, by Application
13.22.1. Central Nervous System (CNS) Surgeries
13.22.2. General Surgeries
13.22.3. Cardiovascular surgeries
13.22.4. Orthopedic Surgeries
13.22.5. Cosmetic Surgeries
13.22.6. Ophthalmic Surgeries
13.22.7. Urological Surgeries
13.22.8. Pulmonary Surgeries
13.23. Australia Biological Sealants Market Forecast, by Product
13.23.1. Natural or Biological
13.23.2. Fibrin
13.23.3. Collagen Based
13.23.4. Synthetic and Semi Synthetic
13.23.5. Cyanoacrylates
13.23.6. Polymeric Hydrogels
13.24. Malaysia Biological Sealants Market Forecast, by Indication
13.24.1. Tissue Sealing
13.24.2. Surgical Hemostasis
13.24.3. Tissue Engineering
13.24.4. Polymeric Hydrogels
13.25. Malaysia Biological Sealants Market Forecast, by Application
13.25.1. Central Nervous System (CNS) Surgeries
13.25.2. General Surgeries
13.25.3. Cardiovascular surgeries
13.25.4. Orthopedic Surgeries
13.25.5. Cosmetic Surgeries
13.25.6. Ophthalmic Surgeries
13.25.7. Urological Surgeries
13.25.8. Pulmonary Surgeries
13.26. Malaysia Biological Sealants Market Forecast, by Product
13.26.1. Natural or Biological
13.26.2. Fibrin
13.26.3. Collagen Based
13.26.4. Synthetic and Semi Synthetic
13.26.5. Cyanoacrylates
13.26.6. Polymeric Hydrogels
13.27. South Korea Biological Sealants Market Forecast, by Indication
13.27.1. Tissue Sealing
13.27.2. Surgical Hemostasis
13.27.3. Tissue Engineering
13.27.4. Polymeric Hydrogels
13.28. South Korea Biological Sealants Market Forecast, by Application
13.28.1. Central Nervous System (CNS) Surgeries
13.28.2. General Surgeries
13.28.3. Cardiovascular surgeries
13.28.4. Orthopedic Surgeries
13.28.5. Cosmetic Surgeries
13.28.6. Ophthalmic Surgeries
13.28.7. Urological Surgeries
13.28.8. Pulmonary Surgeries
13.29. South Korea Biological Sealants Market Forecast, by Product
13.29.1. Natural or Biological
13.29.2. Fibrin
13.29.3. Collagen Based
13.29.4. Synthetic and Semi Synthetic
13.29.5. Cyanoacrylates
13.29.6. Polymeric Hydrogels
13.30. Thailand Biological Sealants Market Forecast, by Indication
13.30.1. Tissue Sealing
13.30.2. Surgical Hemostasis
13.30.3. Tissue Engineering
13.30.4. Polymeric Hydrogels
13.31. Thailand Biological Sealants Market Forecast, by Application
13.31.1. Central Nervous System (CNS) Surgeries
13.31.2. General Surgeries
13.31.3. Cardiovascular surgeries
13.31.4. Orthopedic Surgeries
13.31.5. Cosmetic Surgeries
13.31.6. Ophthalmic Surgeries
13.31.7. Urological Surgeries
13.31.8. Pulmonary Surgeries
13.32. Thailand Biological Sealants Market Forecast, by Product
13.32.1. Natural or Biological
13.32.2. Fibrin
13.32.3. Collagen Based
13.32.4. Synthetic and Semi Synthetic
13.32.5. Cyanoacrylates
13.32.6. Polymeric Hydrogels
13.33. Vietnam Biological Sealants Market Forecast, by Indication
13.33.1. Tissue Sealing
13.33.2. Surgical Hemostasis
13.33.3. Tissue Engineering
13.33.4. Polymeric Hydrogels
13.34. Vietnam Biological Sealants Market Forecast, by Application
13.34.1. Central Nervous System (CNS) Surgeries
13.34.2. General Surgeries
13.34.3. Cardiovascular surgeries
13.34.4. Orthopedic Surgeries
13.34.5. Cosmetic Surgeries
13.34.6. Ophthalmic Surgeries
13.34.7. Urological Surgeries
13.34.8. Pulmonary Surgeries
13.35. Vietnam Biological Sealants Market Forecast, by Product
13.35.1. Natural or Biological
13.35.2. Fibrin
13.35.3. Collagen Based
13.35.4. Synthetic and Semi Synthetic
13.35.5. Cyanoacrylates
13.35.6. Polymeric Hydrogels
13.36. Rest of Asia Pacific Biological Sealants Market Forecast, by Indication
13.36.1. Tissue Sealing
13.36.2. Surgical Hemostasis
13.36.3. Tissue Engineering
13.36.4. Polymeric Hydrogels
13.37. Rest of Asia Pacific Biological Sealants Market Forecast, by Application
13.37.1. Central Nervous System (CNS) Surgeries
13.37.2. General Surgeries
13.37.3. Cardiovascular surgeries
13.37.4. Orthopedic Surgeries
13.37.5. Cosmetic Surgeries
13.37.6. Ophthalmic Surgeries
13.37.7. Urological Surgeries
13.37.8. Pulmonary Surgeries
13.38. Rest of Asia Pacific Biological Sealants Market Forecast, by Product
13.38.1. Natural or Biological
13.38.2. Fibrin
13.38.3. Collagen Based
13.38.4. Synthetic and Semi Synthetic
13.38.5. Cyanoacrylates
13.38.6. Polymeric Hydrogels
13.39. Asia Pacific Biological Sealants Market Attractiveness Analysis
13.39.1. By Indication
13.39.2. By Application
13.39.3. By Product
13.40. PEST Analysis
13.41. Key Trends
13.42. Key Development
14. Middle East & Africa Biological Sealants Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Biological Sealants Market Overview
14.3. Middle East & Africa Biological Sealants Market Value Share Analysis, by Indication
14.4. Middle East & Africa Biological Sealants Market Forecast, by Indication
14.4.1. Tissue Sealing
14.4.2. Surgical Hemostasis
14.4.3. Tissue Engineering
14.4.4. Polymeric Hydrogels
14.5. Middle East & Africa Biological Sealants Market Value Share Analysis, by Application
14.6. Middle East & Africa Biological Sealants Market Forecast, by Application
14.6.1. Central Nervous System (CNS) Surgeries
14.6.2. General Surgeries
14.6.3. Cardiovascular surgeries
14.6.4. Orthopedic Surgeries
14.6.5. Cosmetic Surgeries
14.6.6. Ophthalmic Surgeries
14.6.7. Urological Surgeries
14.6.8. Pulmonary Surgeries
14.7. Middle East & Africa Biological Sealants Market Value Share Analysis, by Product
14.8. Middle East & Africa Biological Sealants Market Forecast, by Product
14.8.1. Natural or Biological
14.8.2. Fibrin
14.8.3. Collagen Based
14.8.4. Synthetic and Semi Synthetic
14.8.5. Cyanoacrylates
14.8.6. Polymeric Hydrogels
14.9. Middle East & Africa Biological Sealants Market Value Share Analysis, by Country
14.10. Middle East & Africa Biological Sealants Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Nigeria
14.10.4. Egypt
14.10.5. Rest of Middle East & Africa
14.11. Middle East & Africa Biological Sealants Market Analysis, by Country
14.12. GCC Biological Sealants Market Forecast, by Indication
14.12.1. Tissue Sealing
14.12.2. Surgical Hemostasis
14.12.3. Tissue Engineering
14.12.4. Polymeric Hydrogels
14.13. GCC Biological Sealants Market Forecast, by Application
14.13.1. Central Nervous System (CNS) Surgeries
14.13.2. General Surgeries
14.13.3. Cardiovascular surgeries
14.13.4. Orthopedic Surgeries
14.13.5. Cosmetic Surgeries
14.13.6. Ophthalmic Surgeries
14.13.7. Urological Surgeries
14.13.8. Pulmonary Surgeries
14.14. GCC Biological Sealants Market Forecast, by Product
14.14.1. Natural or Biological
14.14.2. Fibrin
14.14.3. Collagen Based
14.14.4. Synthetic and Semi Synthetic
14.14.5. Cyanoacrylates
14.14.6. Polymeric Hydrogels
14.15. South Africa Biological Sealants Market Forecast, by Indication
14.15.1. Tissue Sealing
14.15.2. Surgical Hemostasis
14.15.3. Tissue Engineering
14.15.4. Polymeric Hydrogels
14.16. South Africa Biological Sealants Market Forecast, by Application
14.16.1. Central Nervous System (CNS) Surgeries
14.16.2. General Surgeries
14.16.3. Cardiovascular surgeries
14.16.4. Orthopedic Surgeries
14.16.5. Cosmetic Surgeries
14.16.6. Ophthalmic Surgeries
14.16.7. Urological Surgeries
14.16.8. Pulmonary Surgeries
14.17. South Africa Biological Sealants Market Forecast, by Product
14.17.1. Natural or Biological
14.17.2. Fibrin
14.17.3. Collagen Based
14.17.4. Synthetic and Semi Synthetic
14.17.5. Cyanoacrylates
14.17.6. Polymeric Hydrogels
14.18. Nigeria Biological Sealants Market Forecast, by Indication
14.18.1. Tissue Sealing
14.18.2. Surgical Hemostasis
14.18.3. Tissue Engineering
14.18.4. Polymeric Hydrogels
14.19. Nigeria Biological Sealants Market Forecast, by Application
14.19.1. Central Nervous System (CNS) Surgeries
14.19.2. General Surgeries
14.19.3. Cardiovascular surgeries
14.19.4. Orthopedic Surgeries
14.19.5. Cosmetic Surgeries
14.19.6. Ophthalmic Surgeries
14.19.7. Urological Surgeries
14.19.8. Pulmonary Surgeries
14.20. Nigeria Biological Sealants Market Forecast, by Product
14.20.1. Natural or Biological
14.20.2. Fibrin
14.20.3. Collagen Based
14.20.4. Synthetic and Semi Synthetic
14.20.5. Cyanoacrylates
14.20.6. Polymeric Hydrogels
14.21. Egypt Biological Sealants Market Forecast, by Indication
14.21.1. Tissue Sealing
14.21.2. Surgical Hemostasis
14.21.3. Tissue Engineering
14.21.4. Polymeric Hydrogels
14.22. Egypt Biological Sealants Market Forecast, by Application
14.22.1. Central Nervous System (CNS) Surgeries
14.22.2. General Surgeries
14.22.3. Cardiovascular surgeries
14.22.4. Orthopedic Surgeries
14.22.5. Cosmetic Surgeries
14.22.6. Ophthalmic Surgeries
14.22.7. Urological Surgeries
14.22.8. Pulmonary Surgeries
14.23. Egypt Biological Sealants Market Forecast, by Product
14.23.1. Natural or Biological
14.23.2. Fibrin
14.23.3. Collagen Based
14.23.4. Synthetic and Semi Synthetic
14.23.5. Cyanoacrylates
14.23.6. Polymeric Hydrogels
14.24. Rest of Middle East & Africa Biological Sealants Market Forecast, by Indication
14.24.1. Tissue Sealing
14.24.2. Surgical Hemostasis
14.24.3. Tissue Engineering
14.24.4. Polymeric Hydrogels
14.25. Rest of Middle East & Africa Biological Sealants Market Forecast, by Application
14.25.1. Central Nervous System (CNS) Surgeries
14.25.2. General Surgeries
14.25.3. Cardiovascular surgeries
14.25.4. Orthopedic Surgeries
14.25.5. Cosmetic Surgeries
14.25.6. Ophthalmic Surgeries
14.25.7. Urological Surgeries
14.25.8. Pulmonary Surgeries
14.26. Rest of Middle East & Africa Biological Sealants Market Forecast, by Product
14.26.1. Natural or Biological
14.26.2. Fibrin
14.26.3. Collagen Based
14.26.4. Synthetic and Semi Synthetic
14.26.5. Cyanoacrylates
14.26.6. Polymeric Hydrogels
14.27. Middle East & Africa Biological Sealants Market Attractiveness Analysis
14.27.1. By Indication
14.27.2. By Application
14.27.3. By Product
14.28. PEST Analysis
14.29. Key Trends
14.30. Key Development
15. South America Biological Sealants Market Analysis
15.1. Key Findings
15.2. South America Biological Sealants Market Overview
15.3. South America Biological Sealants Market Value Share Analysis, by Indication
15.4. South America Biological Sealants Market Forecast, by Indication
15.4.1. Tissue Sealing
15.4.2. Surgical Hemostasis
15.4.3. Tissue Engineering
15.4.4. Polymeric Hydrogels
15.5. South America Biological Sealants Market Value Share Analysis, by Application
15.6. South America Biological Sealants Market Forecast, by Application
15.6.1. Central Nervous System (CNS) Surgeries
15.6.2. General Surgeries
15.6.3. Cardiovascular surgeries
15.6.4. Orthopedic Surgeries
15.6.5. Cosmetic Surgeries
15.6.6. Ophthalmic Surgeries
15.6.7. Urological Surgeries
15.6.8. Pulmonary Surgeries
15.7. South America Biological Sealants Market Forecast, by Product
15.7.1. Natural or Biological
15.7.2. Fibrin
15.7.3. Collagen Based
15.7.4. Synthetic and Semi Synthetic
15.7.5. Cyanoacrylates
15.7.6. Polymeric Hydrogels
15.8. South America Biological Sealants Market Value Share Analysis, by Country
15.9. South America Biological Sealants Market Forecast, by Country
15.9.1. Brazil
15.9.2. Mexico
15.9.3. Argentina
15.9.4. Rest of South America
15.10. South America Biological Sealants Market Analysis, by Country
15.11. Brazil Biological Sealants Market Forecast, by Indication
15.11.1. Tissue Sealing
15.11.2. Surgical Hemostasis
15.11.3. Tissue Engineering
15.11.4. Polymeric Hydrogels
15.12. Brazil Biological Sealants Market Forecast, by Application
15.12.1. Central Nervous System (CNS) Surgeries
15.12.2. General Surgeries
15.12.3. Cardiovascular surgeries
15.12.4. Orthopedic Surgeries
15.12.5. Cosmetic Surgeries
15.12.6. Ophthalmic Surgeries
15.12.7. Urological Surgeries
15.12.8. Pulmonary Surgeries
15.13. Brazil Biological Sealants Market Forecast, by Product
15.13.1. Natural or Biological
15.13.2. Fibrin
15.13.3. Collagen Based
15.13.4. Synthetic and Semi Synthetic
15.13.5. Cyanoacrylates
15.13.6. Polymeric Hydrogels
15.14. Mexico Biological Sealants Market Forecast, by Indication
15.14.1. Tissue Sealing
15.14.2. Surgical Hemostasis
15.14.3. Tissue Engineering
15.14.4. Polymeric Hydrogels
15.15. Mexico Biological Sealants Market Forecast, by Application
15.15.1. Central Nervous System (CNS) Surgeries
15.15.2. General Surgeries
15.15.3. Cardiovascular surgeries
15.15.4. Orthopedic Surgeries
15.15.5. Cosmetic Surgeries
15.15.6. Ophthalmic Surgeries
15.15.7. Urological Surgeries
15.15.8. Pulmonary Surgeries
15.16. Mexico Biological Sealants Market Forecast, by Product
15.16.1. Natural or Biological
15.16.2. Fibrin
15.16.3. Collagen Based
15.16.4. Synthetic and Semi Synthetic
15.16.5. Cyanoacrylates
15.16.6. Polymeric Hydrogels
15.17. Argentina Biological Sealants Market Forecast, by Indication
15.17.1. Tissue Sealing
15.17.2. Surgical Hemostasis
15.17.3. Tissue Engineering
15.17.4. Polymeric Hydrogels
15.18. Argentina Biological Sealants Market Forecast, by Application
15.18.1. Central Nervous System (CNS) Surgeries
15.18.2. General Surgeries
15.18.3. Cardiovascular surgeries
15.18.4. Orthopedic Surgeries
15.18.5. Cosmetic Surgeries
15.18.6. Ophthalmic Surgeries
15.18.7. Urological Surgeries
15.18.8. Pulmonary Surgeries
15.19. Argentina Biological Sealants Market Forecast, by Product
15.19.1. Natural or Biological
15.19.2. Fibrin
15.19.3. Collagen Based
15.19.4. Synthetic and Semi Synthetic
15.19.5. Cyanoacrylates
15.19.6. Polymeric Hydrogels
15.20. Rest of South America Biological Sealants Market Forecast, by Indication
15.20.1. Tissue Sealing
15.20.2. Surgical Hemostasis
15.20.3. Tissue Engineering
15.20.4. Polymeric Hydrogels
15.21. Rest of South America Biological Sealants Market Forecast, by Application
15.21.1. Central Nervous System (CNS) Surgeries
15.21.2. General Surgeries
15.21.3. Cardiovascular surgeries
15.21.4. Orthopedic Surgeries
15.21.5. Cosmetic Surgeries
15.21.6. Ophthalmic Surgeries
15.21.7. Urological Surgeries
15.21.8. Pulmonary Surgeries
15.22. Rest of South America Biological Sealants Market Forecast, by Product
15.22.1. Natural or Biological
15.22.2. Fibrin
15.22.3. Collagen Based
15.22.4. Synthetic and Semi Synthetic
15.22.5. Cyanoacrylates
15.22.6. Polymeric Hydrogels
15.23. South America Biological Sealants Market Attractiveness Analysis
15.23.1. By Indication
15.23.2. By Application
15.23.3. By Product
15.24. PEST Analysis
15.25. Key Trends
15.26. Key Development
16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Products and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Products
16.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
16.3. Company Profiles: Key Players
16.3.1. Baxter International, Inc.
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Company Footprint
16.3.2. CryoLife, Inc.
16.3.3. C.R. Bard, Inc.
16.3.4. Medtronic PLC
16.3.5. B. Braun Melsungen AG
16.3.6. Cohera Medical, Inc.
16.3.7. Ethicon, Inc. [J&J]
16.3.8. Mallinckrodt plc
16.3.9. Cardinal Health
16.3.10. B. Braun Melsungen AG
16.3.11. Medtronic Plc.
16.3.12. CryoLife, Inc.
16.3.13. Ocular Therapeutix
16.3.14. Sealantis Ltd
16.3.15. Johnson & Johnson (Ethicon, Inc.)
16.3.16. Becton
16.3.17. Dickinson and Company
16.3.18. CryoLife, Inc.
16.3.19. Cardinal Health, Inc.
16.3.20. B. Braun Melsungen AG
16.3.21. Integra Lifesciences Holdings Corporation
16.3.22. Medline Industries, Inc.
16.3.23. Adhezion Biomedical, LLC
16.3.24. Tricol Biomedical, Inc.